Breach Of Fiduciary Duty Claim Against EpiPen Defendants Stands, Federal Judge Says

Mealey's (October 30, 2018, 12:39 PM EDT) -- MINNEAPOLIS — A Minnesota federal judge on Oct. 26 determined that a breach of fiduciary duty claim alleged against a number of defendants in a lawsuit arising out of the increased cost of the EpiPen prescription can stand because the plaintiffs sufficiently alleged facts to support the claim (In re:  EpiPen ERISA Litigation, No. 17-1884, D. Minn., 2018 U.S. Dist. LEXIS 183650)....

Attached Documents

Related Sections